Soft Tissue Sarcoma Market

Request Customization

Soft Tissue Sarcoma Market Research Report – Segmentation by By Treatment Type (Chemotherapy, Targeted Therapy, Immunotherapy), By End-User (Hospitals, Specialty Clinics) ; and Region; - Size, Share, Growth Analysis | Forecast (2025– 2030)

Published: 2025 - Feb

Report Code: VMR-17547

Region: Global

Historic Range: 2022-2024

Forecast: 2025-2031

Format: Excel and PDF

Chapter 1. Report Scope & Methodology

Market Segmentation

1.1 Scope, Assumptions & Limitations
1.2 Research Methodology
1.3 Primary Sources
1.4 Secondary Sources

Chapter 2. Executive Summary

Market Segmentation

2.1 Market Size & Forecast – (2024 – 2030) ($M/$Bn)
2.2 Key Trends & Insights
2.2.1 Demand Side
2.2.2 Supply Side
2.3 Attractive Investment Propositions
2.4 COVID-19 Impact Analysis

📥 Download Sample Report

Fill out the form below and our team will get back to you shortly

The field with (*) is required.

📋 Contact Information

Name *

Email *

Company *

Job Title *

Country *

Phone *

Message (Optional)

Security Verification

This form is protected by Google reCAPTCHA v3. Verification runs automatically when you submit.

Your information is secure and will not be shared with third parties.

FAQ's

The Global Soft Tissue Sarcoma Market was valued at USD 1.58 billion in 2024 and is projected to reach a market size of USD 2.57 billion by the end of 2030. Over the forecast period of 2025-2030, the market is projected to grow at a CAGR of 10.21%.

The incidences of Soft Tissue Sarcoma are increasing and the majority of players in the soft tissue sarcoma market are aiming to develop novel drugs and therapies

Based on Service Provider, the Global Soft Tissue Sarcoma Market is segmented into hospitals, oncology centers, diagnostic laboratories, and research organizations

North America is the most dominant region for the Global Soft Tissue Sarcoma Market.

Pfizer, Eli Lilly, Johnson & Johnson, GSK(GlaxoSmithKline), Roche, Hospira, Eisai, and Bayer are the key players operating in the Global Soft Tissue Sarcoma Market.

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

Select User License Type

Data Spreadsheet: Market data delivered in spreadsheet format for analysis.

Single User: One named user; PDF report access for internal use.

Multi User: Up to five users within the same organization at one location.

Corporate User: Enterprise-wide access across your organization.

Data Spreadsheet

2500

Single User

4250

Multi User

5250

Corporate User

6900

Country-Specific Report

Dive into Country Outlook

Unlock Country Level Outlook, Trends, Cross-country Comparability, or supply Chain Variations.

Access Country Insights

Testimonials

“We received a complex piece of work for our niche market from Virtue Market research in short period of time. I appreciate the quality and content of the final files we received. Thanks for the support”

Medical Devices Company based in Europe